.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
AstraZeneca
Moodys
Argus Health
Mallinckrodt
Farmers Insurance
Covington
Healthtrust
Accenture

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019886

« Back to Dashboard

NDA 019886 describes SYNAREL, which is a drug marketed by Gd Searle Llc and is included in one NDA. It is available from one supplier. Additional details are available on the SYNAREL profile page.

The generic ingredient in SYNAREL is nafarelin acetate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the nafarelin acetate profile page.

Summary for 019886

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Hormonal Agents, Suppressant (Pituitary)
Formulation / Manufacturing:see details

Pharmacology for NDA: 019886

Medical Subject Heading (MeSH) Categories for 019886

Suppliers and Packaging for NDA: 019886

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SYNAREL nafarelin acetate SPRAY, METERED;NASAL 019886 NDA G.D. Searle LLC Division of Pfizer Inc 0025-0166 0025-0166-08 1 BOTTLE, SPRAY in 1 CARTON (0025-0166-08) > 8 mL in 1 BOTTLE, SPRAY

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SPRAY, METERED;NASALStrengthEQ 0.2MG BASE/SPRAY
Approval Date:Feb 13, 1990TE:RLD:Yes

Expired Orange Book Patents for NDA: 019886

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gd Searle LlcSYNARELnafarelin acetateSPRAY, METERED;NASAL019886-001Feb 13, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Teva
Cantor Fitzgerald
Accenture
Baxter
Chubb
Argus Health
Harvard Business School
Merck
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot